Given the importance in cancer of the anti-apoptotic proteins of the Bcl2 family15 of which Bcl-xL is a member and the focus on therapies that inhibit Bcl-xL, it becomes relevant to provide an understanding of any positive regulators of Bcl-xL. Here, BCL2L1 is linked to cancer.